Literature DB >> 18200501

Systemic autoimmunity in BAFF-R-mutant A/WySnJ strain mice.

Christopher G Mayne1, Ian J Amanna, Faye E Nashold, Colleen E Hayes.   

Abstract

Systemic lupus erythematosis is an autoimmune disease of unknown etiology. Lupus pathology is thought to reflect autoantibody-mediated damage due to a failure of B lymphocyte tolerance. Since excessive B cell-activating factor belonging to the TNF family (BAFF) expression correlates with human and murine lupus, and BAFF signals B cell survival through BAFF-R, it is believed that excessive BAFF-R signaling can subvert B cell tolerance and facilitate lupus development. Here we report the unexpected finding that BAFF-R-mutant A/WySnJ mice develop a lupus-like syndrome. These mice carry the B cell maturation defect-1 (Bcmd-1) mutant allele of the Baffr gene. Bcmd-1 causes premature B cell death and profound B cell deficiency. Despite having 90% fewer splenic B cells than normal mice, A/WySnJ mice had an 18-fold increased frequency of splenocytes secreting IgM antibodies to dsDNA, and increased amounts of circulating IgM and IgG to dsDNA by 9 months of age. By age 11 months, most A/WySnJ mice displayed renal pathology characteristic of lupus, including proteinuria as well as periodic acid-Schiff-positive deposits and glomerular capillary bed destruction. Importantly, we genetically linked this autoimmunity to Bcmd-1, since congenic AW.Baffr(+/+) mice carrying a wild-type allele developed none of these phenotypes. Our data provide the first evidence linking altered BAFF-R signaling to the development of B cell-mediated autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18200501      PMCID: PMC2981162          DOI: 10.1002/eji.200737817

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  48 in total

1.  TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease.

Authors:  J A Gross; J Johnston; S Mudri; R Enselman; S R Dillon; K Madden; W Xu; J Parrish-Novak; D Foster; C Lofton-Day; M Moore; A Littau; A Grossman; H Haugen; K Foley; H Blumberg; K Harrison; W Kindsvogel; C H Clegg
Journal:  Nature       Date:  2000-04-27       Impact factor: 49.962

2.  Analysis of the regulatory role of BAFF in controlling the expression of CD21 and CD23.

Authors:  Irina Debnath; Kirstin M Roundy; Janis J Weis; John H Weis
Journal:  Mol Immunol       Date:  2006-11-30       Impact factor: 4.407

Review 3.  Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease.

Authors:  Anna-Marie Fairhurst; Amy E Wandstrat; Edward K Wakeland
Journal:  Adv Immunol       Date:  2006       Impact factor: 3.543

Review 4.  B-1 B cell development.

Authors:  Richard R Hardy
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

5.  Reduced synaptic vesicle density and aberrant synaptic localization caused by a splice site mutation in the Rs1h gene.

Authors:  Britt A Johnson; Sakae Ikeda; Lawrence H Pinto; Akihiro Ikeda
Journal:  Vis Neurosci       Date:  2006 Nov-Dec       Impact factor: 3.241

6.  Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells.

Authors:  M S Bynoe; C M Grimaldi; B Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

7.  Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease.

Authors:  A Strasser; S Whittingham; D L Vaux; M L Bath; J M Adams; S Cory; A W Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

8.  Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations.

Authors:  F Mackay; S A Woodcock; P Lawton; C Ambrose; M Baetscher; P Schneider; J Tschopp; J L Browning
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307

Review 9.  Toll-like receptors in systemic autoimmune disease.

Authors:  Ann Marshak-Rothstein
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106

10.  BAFF and MyD88 signals promote a lupuslike disease independent of T cells.

Authors:  Joanna R Groom; Carrie A Fletcher; Stacey N Walters; Shane T Grey; Sally V Watt; Mathew J Sweet; Mark J Smyth; Charles R Mackay; Fabienne Mackay
Journal:  J Exp Med       Date:  2007-07-30       Impact factor: 14.307

View more
  9 in total

1.  Regulation of B cell activating factor (BAFF) receptor expression by NF-ΚB signaling in rheumatoid arthritis B cells.

Authors:  Yun Ju Woo; Bo Young Yoon; Joo Yeon Jhun; Hye Jwa Oh; Se Won Min; Mi La Cho; Sung Hwan Park; Ho Youn Kim; Jun Ki Min
Journal:  Exp Mol Med       Date:  2011-06-30       Impact factor: 8.718

Review 2.  Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.

Authors:  Bharat B Aggarwal; Subash C Gupta; Ji Hye Kim
Journal:  Blood       Date:  2011-11-03       Impact factor: 22.113

3.  The adaptor molecule Act1 regulates BAFF responsiveness and self-reactive B cell selection during transitional B cell maturation.

Authors:  Natalia V Giltiay; Yi Lu; David Allman; Trine N Jørgensen; Xiaoxia Li
Journal:  J Immunol       Date:  2010-06-11       Impact factor: 5.422

4.  Expansion of immunoglobulin-secreting cells and defects in B cell tolerance in Rag-dependent immunodeficiency.

Authors:  Jolan E Walter; Francesca Rucci; Laura Patrizi; Mike Recher; Stephan Regenass; Tiziana Paganini; Marton Keszei; Itai Pessach; Philipp A Lang; Pietro Luigi Poliani; Silvia Giliani; Waleed Al-Herz; Morton J Cowan; Jennifer M Puck; Jack Bleesing; Tim Niehues; Catharina Schuetz; Harry Malech; Suk See DeRavin; Fabio Facchetti; Andrew R Gennery; Emma Andersson; Naynesh R Kamani; JoAnn Sekiguchi; Hamid M Alenezi; Javier Chinen; Ghassan Dbaibo; Gehad ElGhazali; Adriano Fontana; Srdjan Pasic; Cynthia Detre; Cox Terhorst; Frederick W Alt; Luigi D Notarangelo
Journal:  J Exp Med       Date:  2010-06-14       Impact factor: 14.307

5.  Murine BAFF-receptor residues 168-175 are essential for optimal CD21/35 expression but dispensable for B cell survival.

Authors:  Christopher G Mayne; Ian J Amanna; Colleen E Hayes
Journal:  Mol Immunol       Date:  2009-10-07       Impact factor: 4.407

6.  Altered BAFF-receptor signaling and additional modifier loci contribute to systemic autoimmunity in A/WySnJ mice.

Authors:  Christopher G Mayne; Faye E Nashold; Yoshiteru Sasaki; Colleen E Hayes
Journal:  Eur J Immunol       Date:  2009-02       Impact factor: 5.532

7.  Association of BAFF with PI3K/Akt/mTOR signaling in lupus nephritis.

Authors:  Fengmei Ge; Fangfang Wang; Xiuqing Yan; Zhao Li; Xuebin Wang
Journal:  Mol Med Rep       Date:  2017-08-28       Impact factor: 2.952

8.  Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression.

Authors:  Madeleine V Pahl; Sastry Gollapudi; Lili Sepassi; Pavan Gollapudi; Reza Elahimehr; Nosratola D Vaziri
Journal:  Nephrol Dial Transplant       Date:  2009-08-14       Impact factor: 5.992

9.  MRL Strains Have a BAFFR Mutation without Functional Consequence.

Authors:  Windy R Allman; Lunhua Liu; Adam S Coleman; Mustafa Akkoyunlu
Journal:  PLoS One       Date:  2016-05-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.